Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesSchwannoma with monoclonal plasma cell infiltration
Journal of Neurosurgery, 09/08/09
Plaut J et al. – The authors report a very rare case of a vestibular schwannoma with an infiltrate of monoclonal plasma cells. A 45–year–old woman underwent routine excision of a presumed vestibular schwannoma. Histological analysis revealed the presence of a distinct lambda light chain restricted plasma cell population within the schwannoma. The light chain restriction and polymerase chain reaction–demonstrated monoclonality of the plasma cell population suggested the co–occurrence of a plasma cell neoplasm within a schwannoma.
Related Articles
Giant sacral schwannoma A case report and review of the literature
Acta Orthopaedica Belgica, 11/17/09
Relevance Score: 88%
A Case of High-Grade Undifferentiated Sarcoma after Surgical Resection and Stereotactic Radiosurgery of a Vestibular Schwannoma
Skull Base, 11/10/09
Relevance Score: 87%
A contemporary review of balance dysfunction following vestibular schwannoma surgery
The Laryngoscope, 10/07/09
Relevance Score: 87%
Trends in the management of vestibular schwannomas at Johns Hopkins 1997-2007
The Laryngoscope, 11/06/09
Relevance Score: 85%
Signal intensity change of the labyrinth in patients with surgically confirmed or radiologically diagnosed vestibular schwannoma on isotropic 3D fluid-attenuated inversion recovery MR imaging at 3 T
European Radiology, 11/11/09
Relevance Score: 84%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A heritable predisposition to pituitary tumors
Pituitary, 12/18/09
Temozolomide (Temodar) and capecitabine (Xeloda) treatment of an aggressive corticotroph pituitary tumor
Pituitary, 12/18/09
Complete percutaneous treatment of vertebral body tumors causing spinal canal compromise using a transpedicular cavitation, cement augmentation, and radiosurgical technique
Neurosurgical Focus, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor